JNK3 contributes to c-jun induction and apoptosis in 4-hydroxynonenal-treated sympathetic neurons

Journal of Neuroscience Research

Volumn 70, Issue 5, 2002, Pages 665-670

  Bruckner, Shane R ^a   Estus, Steven ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b NONE   (United States)

Author keywords

Apoptosis; HNE; JNK; Oxidative stress; Programmed cell death; Sympathetic neuron

Indexed keywords

4 HYDROXYNONENAL; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL TYPE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME DEFICIENCY; FETUS; GENE INDUCTION; LIPID PEROXIDATION; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; RAT; SYMPATHETIC NERVE CELL;

ALDEHYDES; ANIMALS; APOPTOSIS; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; MICE; MICE, MUTANT STRAINS; MITOGEN-ACTIVATED PROTEIN KINASE 10; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-JUN; RATS; SUPERIOR CERVICAL GANGLION;

EID: 0036893515     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10437     Document Type: Article

References (32)

1. Beal MF. 1995. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357-366.
2. Bruckner SR, Tammariello SP, Kuan CY, Flavell RA, Rakic P, Estus S. 2001. JNK3 contributes to c-Jun activation and apoptosis but not oxidative stress in nerve growth factor-deprived sympathetic neurons. J Neurochem 78:298-303.
3. Butterfield DA, Drake J, Pocernich C, Castegna A. 2001. Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid beta-peptide. Trends Mol Med 7:548-554.
4. Camandola S, Poli G, Mattson MP. 2000. The lipid peroxidation product 4-hydroxy-2,3-nonenal increases AP-1-binding activity through caspase activation in neurons. J Neurochem 74:159-168.
5. Dexter DT, Holley AE, Flitter WD, Slater TF, Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD. 1994. Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study. Mov Disord 9:92-97.
6. Eilers A, Whitfield J, Babij C, Rubin LL, Ham J. 1998. Role of the Jun kinase pathway in the regulation of c-Jun expression and apoptosis in sympathetic neurons. J Neurosci 18:1713-1724.
7. Esterbauer H, Schaur RJ, Zollner H. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81-128.
8. Estus S, Zaks W, Freeman R, Gruda M, Bravo R, Johnson E. 1994. Altered gene expression in neurons during programmed cell death; identification of c-jun as necessary for neuronal apoptosis. J Cell Biol 127:1717-1727.
9. Estüs S, Tucker HM, van Rooyen C, Wright S, Brigham E, Wogulis M, Rydel R. 1997. Aggregated amyloid-β protein induces cortical neuronal apoptosis and concomitant "apoptotic" pattern of gene induction. J Neurosci 17:7736-7745.
10. Greenlund LJ, Deckwerth TL, Johnson EM Jr. 1995. Superoxide dismutase delays neuronal apoptosis: A role for reactive oxygen species in programmed neuronal death. Neuron 14:303-315.
11. Harris CA, Deshmukh M, Tsui-Pierchala B, Maroney AC, Johnson EM Jr. 2002. Inhibition of the c-Jun N-terminal kinase signaling pathway by the mixed lineage kinase inhibitor CEP-1347 (KT7515) preserves metabolism and growth of trophic factor-deprived neurons. J Neurosci 22:103-113.
12. Ito A, Horigome K. 1995. Ceramide prevents neuronal programmed cell death induced by nerve growth factor deprivation. J Neurochem 65:463-466.
13. Ji C, Kozak KR, Marnett LJ. 2001. IkappaB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal. J Biol Chem 276:18223-18228.
14. Keller JN, Mattson MP. 1998. Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system. Rev Neurosci 9:105-116.
15. Kruman I, Bruce-Keller AJ, Bredesen D, Waeg G, Mattson MP. 1997. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci 17:5089-5100.
16. Lovell MA, Ehmann WD, Mattson MP, Markesbery WR. 1997. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol Aging 18:457-461.
17. Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP. 1997. Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: Involvement of membrane lipid peroxidation. J Neurosci 17:1046-1054.
18. Markesbery WR, Lovell MA. 1998. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 19:33-36.
19. Maroney AC, Finn JP, Bozyczko-Coyne D, O'Kane TM, Neff NT, Tolkovsky AM, Park DS, Yan CY, Troy CM, Greene LA. 1999. CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults. J Neurochem 73:1901-1912.
20. Maroney AC, Finn JP, Connors TJ, Durkin JT, Angeles T, Gessner G, Xu Z, Meyer SL, Savage MJ, Greene LA, Scott RW, Vaught JL. 2001. Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family. J Biol Chem 276:25302-25308.
21. McKracken E, Graham DI, Nilsen M, Stewart J, Nicoll JA, Horsburgh K. 2001. 4-Hydroxynonenal immunoreactivity is increased in human hippocampus after global ischemia. Brain Pathol 11:414-421.
22. Parola M, Robino G, Marra F, Pinzani M, Bellomo G, Leonarduzzi G, Chiarugi P, Camandola S, Poli G, Waeg G, Gentilini P, Dianzani MU. 1998. HNE interacts directly with JNK isoforms in human hepatic stellate cells. J Clin Invest 102:1942-1950.
23. Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA. 1997. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 68:2092-2097.
24. Shimizu S, Narita M, Tsujimoto Y. 1999. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399:483-487.
25. Soh Y, Jeong KS, Lee IJ, Bae MA, Kim YC, Song BJ. 2000. Selective activation of the c-Jun N-terminal protein kinase pathway during 4-hydroxynonenal-induced apoptosis of PC12 cells. Mol Pharmacol 58: 535-541.
26. Springer JE, Azbill RD, Mark RJ, Begley JG, Waeg G, Mattson MP. 1997. 4-hydroxynonenal, a lipid peroxidation product, rapidly accumulates following traumatic spinal cord injury and inhibits glutamate uptake. J Neurochem 68:2469-2476.
27. Tammariello SP, Quinn MT, Estus S. 2000. NADPH oxidase contributes directly to oxidative stress and apoptosis in nerve growth factor-deprived sympathetic neurons. J Neurosci 20:RC53.
28. Tammariello SP, Landreth GE, Estus S. 2001. The role of Jun kinases in apoptosis. In: Mattson MP, Estus S, Rangnekar V, editors. Programmed Cell Death: Cellular and Molecular Mechanisms, Vol 1. New York: Elsevier. p 197-214.
29. Uchida K, Shiraishi M, Naito Y, Torii Y, Nakamura Y, Osawa T. 1999. Activation of stress signaling pathways by the end product of lipid peroxidation. 4-Hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J Biol Chem 274:2234-2242.
30. Virdee K, Bannister AJ, Hunt SP, Tolkovsky AM. 1997. Comparison between the timing of JNK activation, c-Jun phosphorylation, and onset of death commitment in sympathetic neurones. J Neurochem 69:550-561.
31. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331.
32. Yang DD, Kuan CY, Whitmarsh AJ, Rincon M, Zheng TS, Davis RJ, Rakic P, Flavell RA. 1997. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389:865-870.